RMR Wealth Builders’s NovoCure NVCR Stock Holding History

RMR Wealth Builders’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-62	Closed	-$8K	–	508
2021 Q1	$8K	Hold	62	–	–	﹤0.01%	620
2020 Q4	$11K	Buy	+62	New	+$8.48K	0.01%	405

Other funds holding NVCR

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RMR Wealth Builders's NVCR Position: Q2 2021 in Review

RMR Wealth Builders sold out of NovoCure (NVCR) in Q2 2021, closing a stake of 62 shares — an estimated $8K sold.

RMR Wealth Builders first reported a position in NVCR in Q4 2020 and held it in 2 quarters. The position peaked at $11K in Q4 2020. 361 funds tracked by Wall St. Rank hold NVCR as of Q2 2021.

RMR Wealth Builders reported no remaining NovoCure position as of Q2 2021 after selling out during the quarter.
RMR Wealth Builders sold 62 NovoCure shares in Q2 2021, an estimated $8K.
RMR Wealth Builders first reported a position in NovoCure in Q4 2020 and held it in 2 quarters.
RMR Wealth Builders's NovoCure position peaked at $11K in Q4 2020.
361 funds tracked by Wall St. Rank held NovoCure as of Q2 2021.

Based on RMR Wealth Builders's 13F filing for Q2 2021, filed 16 Aug 2021.